Numéro 28 - mars 2005

Numéro bibliothèque: ThèsedeDoctoratdel’universitéParisVI

The deployment of Self-Organizing Networks (SONs) raises a number of key design issues such as scalability, spontaneity, ease-of-management, adaptability, and dynamicallychanging topologies. In this context, routing is particularly challenging, and requires revisiting important components of the routing architecture/protocol suite, such as, establishing and managing an addressing scheme, provid...

Drug Safety 2005; 28 (5): 379-386

The WHO World Alliance on Patient Safety is a new, all encompassing project Abstract to improve medical care. Individual patients are the focus and all countries are encouraged to develop systems in which medical error, therapeutic accidents and failures are minimised. The potential for adverse events is present at all levels of healthcare and in all disciplines. One working group in the Allian...

Drug Safety 2005; 28 (6): 529-545

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 529 1. Changes in Pharmacokinetics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 530 1.1 Drug Absorption . . . . . . . . . . . . . . . . . . . . . . . . . ...

Drug Safety 2005; 28 (8): 651-658

In major medical journals, as well as in the public 1. Postmarketing Studies Confirmed the Early Signals media, it has been said that regulators have not managed the risk issues of rofecoxib (Vioxx®)1 A review of the discussions in the WHO email well. The Canadian Medical Association is even conference system (Vigimed) and discussions at calling for a new body to be set up to monitor drug subse...

Drug Safety 2005; 28 (6): 547-556